Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ayako Suzuki"'
Autor:
Katsuya Tsuchihara, Koichi Goto, Takehiko Sasaki, Hiroyasu Esumi, Atsushi Ochiai, Masahiro Tsuboi, Genichiro Ishii, Seiji Niho, Shingo Matsumoto, Sachiyo Mimaki, Hibiki Udagawa, Ami Maruyama, Hiroki Nakanishi, Ayako Suzuki, Shigeki Umemura, Hideki Makinoshima
Supplemental Experimental Procedures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b265538a4e1a4337c5c6c94fae8f1038
https://doi.org/10.1158/0008-5472.22417869
https://doi.org/10.1158/0008-5472.22417869
Autor:
Susumu S. Kobayashi, Yutaka Suzuki, Katsuya Tsuchihara, Koichi Goto, Masahide Seki, Akihiro Ohashi, Masanori Fujii, Kosuke Tanaka, Yuji Shibata, Hiroki Izumi, Hibiki Udagawa, David Plotnick, Ikei S. Kobayashi, Kyoko Muto, Ayako Suzuki, Daisuke Shibahara, Yukie Kashima
Supplemental Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c859d80b945fc738e4748387f96f4a
https://doi.org/10.1158/0008-5472.22428058
https://doi.org/10.1158/0008-5472.22428058
Autor:
Susumu S. Kobayashi, Yutaka Suzuki, Katsuya Tsuchihara, Koichi Goto, Masahide Seki, Akihiro Ohashi, Masanori Fujii, Kosuke Tanaka, Yuji Shibata, Hiroki Izumi, Hibiki Udagawa, David Plotnick, Ikei S. Kobayashi, Kyoko Muto, Ayako Suzuki, Daisuke Shibahara, Yukie Kashima
Supplementary Figure S1 to S6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeda8a890dcbc99cfb9b8ee3285a5571
https://doi.org/10.1158/0008-5472.22428064
https://doi.org/10.1158/0008-5472.22428064
Autor:
Susumu S. Kobayashi, Yutaka Suzuki, Katsuya Tsuchihara, Koichi Goto, Masahide Seki, Akihiro Ohashi, Masanori Fujii, Kosuke Tanaka, Yuji Shibata, Hiroki Izumi, Hibiki Udagawa, David Plotnick, Ikei S. Kobayashi, Kyoko Muto, Ayako Suzuki, Daisuke Shibahara, Yukie Kashima
Tumor heterogeneity underlies resistance to tyrosine kinase inhibitors (TKI) in lung cancers harboring EGFR mutations. Previous evidence suggested that subsets of preexisting resistant cells are selected by EGFR-TKI treatment, or alternatively, that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca179395199d1b79ba39e1f0e12a3b55
https://doi.org/10.1158/0008-5472.c.6512902.v1
https://doi.org/10.1158/0008-5472.c.6512902.v1
Autor:
Katsuya Tsuchihara, Koichi Goto, Takehiko Sasaki, Hiroyasu Esumi, Atsushi Ochiai, Masahiro Tsuboi, Genichiro Ishii, Seiji Niho, Shingo Matsumoto, Sachiyo Mimaki, Hibiki Udagawa, Ami Maruyama, Hiroki Nakanishi, Ayako Suzuki, Shigeki Umemura, Hideki Makinoshima
Supplementary figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::445a0e475ded8c0d6c88e600fbc7642b
https://doi.org/10.1158/0008-5472.22417860
https://doi.org/10.1158/0008-5472.22417860
Autor:
Katsuya Tsuchihara, Koichi Goto, Takehiko Sasaki, Hiroyasu Esumi, Atsushi Ochiai, Masahiro Tsuboi, Genichiro Ishii, Seiji Niho, Shingo Matsumoto, Sachiyo Mimaki, Hibiki Udagawa, Ami Maruyama, Hiroki Nakanishi, Ayako Suzuki, Shigeki Umemura, Hideki Makinoshima
Supplementary Fig. S1. The mean baseline Levels of PIP3 (38:4) per mg tissue in xenograft models transplanted with SCLC cells Supplementary Fig. S2. Metabolic alteration in SCLC cells treated with gedatolisib in vitro and in vivo Supplementary Fig. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5916a3e558707fa4bb0a242d145d508e
https://doi.org/10.1158/0008-5472.22417863.v1
https://doi.org/10.1158/0008-5472.22417863.v1
Autor:
Katsuya Tsuchihara, Koichi Goto, Takehiko Sasaki, Hiroyasu Esumi, Atsushi Ochiai, Masahiro Tsuboi, Genichiro Ishii, Seiji Niho, Shingo Matsumoto, Sachiyo Mimaki, Hibiki Udagawa, Ami Maruyama, Hiroki Nakanishi, Ayako Suzuki, Shigeki Umemura, Hideki Makinoshima
Supplementary Table S1. The pathway classification of metabolites used for the MSEA Supplementary Table S2. Genetic profiles in 42 SCLC cell lines Supplementary Table S3. Quantitative phospho-peptide analysis in H1048 cells with or without Gedatolisi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1174a1c3087ad33026c30ab96568f591
https://doi.org/10.1158/0008-5472.22417866.v1
https://doi.org/10.1158/0008-5472.22417866.v1
Autor:
Katsuya Tsuchihara, Koichi Goto, Takehiko Sasaki, Hiroyasu Esumi, Atsushi Ochiai, Masahiro Tsuboi, Genichiro Ishii, Seiji Niho, Shingo Matsumoto, Sachiyo Mimaki, Hibiki Udagawa, Ami Maruyama, Hiroki Nakanishi, Ayako Suzuki, Shigeki Umemura, Hideki Makinoshima
Comprehensive genomic analysis has revealed that the PI3K/AKT/mTOR pathway is a feasible therapeutic target in small-cell lung carcinoma (SCLC). However, biomarkers to identify patients likely to benefit from inhibitors of this pathway have not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::133bf576ebca7ebe64ef003e3e6c2f58
https://doi.org/10.1158/0008-5472.c.6509964.v1
https://doi.org/10.1158/0008-5472.c.6509964.v1
Autor:
Ikei S. Kobayashi, Daisuke Shibahara, Yuji Shibata, Akihiro Ohashi, Yukie Kashima, Katsuya Tsuchihara, Yutaka Suzuki, Kosuke Tanaka, Koichi Goto, Hiroki Izumi, Masanori Fujii, Ayako Suzuki, Hibiki Udagawa, Susumu Kobayashi, David Plotnick, Kyoko Muto, Masahide Seki
Publikováno v:
Cancer Res
Tumor heterogeneity underlies resistance to tyrosine kinase inhibitors (TKI) in lung cancers harboring EGFR mutations. Previous evidence suggested that subsets of preexisting resistant cells are selected by EGFR-TKI treatment, or alternatively, that
Autor:
Shigeki Umemura, Hiroki Nakanishi, Masahiro Tsuboi, Koichi Goto, Takehiko Sasaki, Shingo Matsumoto, Atsushi Ochiai, Hiroyasu Esumi, Seiji Niho, Katsuya Tsuchihara, Genichiro Ishii, Sachiyo Mimaki, Ami Maruyama, Hideki Makinoshima, Ayako Suzuki, Hibiki Udagawa
Publikováno v:
Cancer Research. 78:2179-2190
Comprehensive genomic analysis has revealed that the PI3K/AKT/mTOR pathway is a feasible therapeutic target in small-cell lung carcinoma (SCLC). However, biomarkers to identify patients likely to benefit from inhibitors of this pathway have not been